文献速递重症综合管理与镇静镇痛

重症患者症状性静脉血栓栓塞症的预测:ICU-静脉血栓栓塞症评分

Prediction of Symptomatic Venous Thromboembolism in Critically Ill Patients: The ICU-Venous Thromboembolism Score.
PubMed 文献 · Crit Care Med · 2020-01-01
一句话结论ICU-静脉血栓栓塞症评分由6项独立预测因子构成,可将ICU患者按评分0-8、9-14、15-18分为低(0.3%)、中(3.6%)、高(17.7%)症状性静脉血栓栓塞症风险三层。

该回顾性队列研究纳入2015年1月至2018年3月期间在五家医院18个ICU收治的37,050例成人患者,症状性静脉血栓栓塞症定义为入ICU 24小时后经超声、CT或核医学影像确诊的深静脉血栓、肺栓塞或两者兼有。529例(1.4%)发生症状性静脉血栓栓塞症。通过多变量logistic回归识别独立危险因素并构建ICU-静脉血栓栓塞症评分,含中心静脉置管(5分)、制动≥4天(4分)、既往静脉血栓栓塞症史(4分)、机械通气(2分)、住院期间最低血红蛋白≥9 g/dL(2分)、入院血小板计数>250,000/μL(1分)。评分0-8分(占76%)风险低(0.3%),9-14分(占22%)风险中等(3.6%,HR 6.7,95%CI 5.3-8.4),15-18分(占2%)风险高(17.7%,HR 28.1,95%CI 21.7-36.5),模型总体C统计量为0.87(95%CI 0.85-0.88)。

要点

  • 评分0-8分(占76%)症状性静脉血栓栓塞症风险0.3%,9-14分(占22%)风险3.6%(HR 6.7,95%CI 5.3-8.4),15-18分(占2%)风险17.7%(HR 28.1,95%CI 21.7-36.5)。
  • 评分6项预测因子及分值:中心静脉置管5分、制动≥4天4分、既往静脉血栓栓塞症史4分、机械通气2分、住院期间最低血红蛋白≥9 g/dL 2分、入院血小板计数>250,000/μL 1分。
  • 模型总体C统计量0.87(95%CI 0.85-0.88)。
  • 中心静脉置管和制动是潜在可干预的静脉血栓栓塞症危险因素。
  • 症状性静脉血栓栓塞症定义为入ICU 24小时后经超声、CT或核医学影像确诊的深静脉血栓、肺栓塞或两者兼有,在37,050例中发生529例(1.4%)。

适用人群与场景

  • 2015年1月至2018年3月期间入住亨利福特医疗系统(含18个ICU、共264张床)任何ICU的成人患者,共37,050例符合纳入标准。

诊断标准与关键阈值

  • 症状性静脉血栓栓塞症定义为入ICU 24小时后经超声、CT或核医学影像确诊的深静脉血栓、肺栓塞或两者兼有。
  • ICU-静脉血栓栓塞症评分分层:0-8分为低风险,9-14分为中等风险,15-18分为高风险。

研究设计与关键结果

  • 回顾性队列研究,纳入37,050例成人ICU患者,529例(1.4%)发生症状性静脉血栓栓塞症。
  • 评分0-8分(占76%)静脉血栓栓塞症风险0.3%;9-14分(占22%)风险3.6%,HR 6.7(95%CI 5.3-8.4);15-18分(占2%)风险17.7%,HR 28.1(95%CI 21.7-36.5)。
  • 模型总体C统计量0.87(95%CI 0.85-0.88)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • ICU-静脉血栓栓塞症评分可识别静脉血栓栓塞症风险升高的患者。
  • 中心静脉置管和制动是潜在可干预的静脉血栓栓塞症危险因素。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To identify risk factors and develop a prediction score for in-hospital symptomatic venous thromboembolism in critically ill patients.

DESIGN: Retrospective cohort study.

SETTING: Henry Ford Health System, a five-hospital system including 18 ICUs.

PATIENTS: We obtained data from the electronic medical record of all adult patients admitted to any ICU (total 264 beds) between January 2015 and March 2018.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Symptomatic venous thromboembolism was defined as deep vein thrombosis, pulmonary embolism, or both, diagnosed greater than 24 hours after ICU admission and confirmed by ultrasound, CT, or nuclear medicine imaging. A prediction score (the ICU-Venous Thromboembolism score) was derived from independent risk factors identified using multivariable logistic regression. Of 37,050 patients who met the eligibility criteria, 529 patients (1.4%) developed symptomatic venous thromboembolism. The ICU-Venous Thromboembolism score consists of six independent predictors: central venous catheterization (5 points), immobilization greater than or equal to 4 days (4 points), prior history of venous thromboembolism (4 points), mechanical ventilation (2 points), lowest hemoglobin during hospitalization greater than or equal to 9 g/dL (2 points), and platelet count at admission greater than 250,000/μL (1 point). Patients with a score of 0-8 (76% of the sample) had a low (0.3%) risk of venous thromboembolism; those with a score of 9-14 (22%) had an intermediate (3.6%) risk of venous thromboembolism (hazard ratio, 6.7; 95% CI, 5.3-8.4); and those with a score of 15-18 (2%) had a high (17.7%) risk of venous thromboembolism (hazard ratio, 28.1; 95% CI, 21.7-36.5). The overall C-statistic of the model was 0.87 (95% CI, 0.85-0.88).

CONCLUSIONS: Clinically diagnosed symptomatic venous thromboembolism occurred in 1.4% of this large population of ICU patients with high adherence to chemoprophylaxis. Central venous catheterization and immobilization are potentially modifiable risk factors for venous thromboembolism. The ICU-Venous Thromboembolism score can identify patients at increased risk for venous thromboembolism.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Viarasilpa T, Panyavachiraporn N, Marashi SM, et al. Prediction of Symptomatic Venous Thromboembolism in Critically Ill Patients: The ICU-Venous Thromboembolism Score. Crit Care Med. 2020. PMID: 32187076. doi:10.1097/CCM.0000000000004306

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。